Acute myeloid leukemia, version 3.2017: Clinical Practice Guidelines in Oncology Journal Article
| Authors: | O'Donnell, M. R.; Tallman, M. S.; Abboud, C. N.; Altman, J. K.; Appelbaum, F. R.; Arber, D. A.; Bhatt, V.; Bixby, D.; Blum, W.; Coutre, S. E.; De Lima, M.; Fathi, A. T.; Fiorella, M.; Foran, J. M.; Gore, S. D.; Hall, A. C.; Kropf, P.; Lancet, J.; Maness, L. J.; Marcucci, G.; Martin, M. G.; Moore, J. O.; Olin, R.; Peker, D.; Pollyea, D. A.; Pratz, K.; Ravandi, F.; Shami, P. J.; Stone, R. M.; Strickland, S. A.; Wang, E. S.; Wieduwilt, M.; Gregory, K.; Ogba, N. |
| Article Title: | Acute myeloid leukemia, version 3.2017: Clinical Practice Guidelines in Oncology |
| Abstract: | Acute myeloid leukemia (AML) is the most common form of acute leukemia among adults and accounts for the largest number of annual deaths due to leukemias in the United States. This portion of the NCCN Guidelines for AML focuses on management and provides recommendations on the workup, diagnostic evaluation, and treatment options for younger (age <60 years) and older (age ≥60 years) adult patients. © JNCCN-Journal of the National Comprehensive Cancer Network. |
| Journal Title: | Journal of the National Comprehensive Cancer Network |
| Volume: | 15 |
| Issue: | 7 |
| ISSN: | 1540-1405 |
| Publisher: | Harborside Press |
| Date Published: | 2017-07-01 |
| Start Page: | 926 |
| End Page: | 957 |
| Language: | English |
| DOI: | 10.6004/jnccn.2017.0116 |
| PROVIDER: | scopus |
| PUBMED: | 28687581 |
| DOI/URL: | |
| Notes: | Review -- Export Date: 2 August 2017 -- Source: Scopus |
